29 October 2021: Original Paper
Impact of the Share 35 Policy on Perioperative Management and Mortality in Liver Transplantation Recipients
Warangkana Lapisatepun 12ABCDEF , Vatche G. Agopian 3BDE , Victor W. Xia 1ADEF , Worakitti Lapisatepun 34ABCDEF*DOI: 10.12659/AOT.932895
Ann Transplant 2021; 26:e932895
Table 2 Intraoperative data of pre- and post-Share 35 transplantation.
| Pre-Share 35N= 859 | Post-Share 35N=737 | P value | |
|---|---|---|---|
| Red blood cell transfusion (units) | 15.0 (9.0–26.0) | 19.0 (10.0–30.0) | * |
| Fresh frozen plasma transfusion (units) | 20.0 (11.0–31.0) | 21.0 (12.0–34.0) | 0.284 |
| RBC: FFP ratio | 1.2 (1.0–1.5) | 1.0 (1.0–1.2) | * |
| Total albumin infusion (ml) | 1000.0 (0.0–2000.0) | 1500.0 (500.0–3000.0) | * |
| Total crystalloid infusion (ml) | 2800.0 (2000.0–3500.0) | 2700.0 (2000.0–3500.0) | 0.381 |
| Albumin: Crystalloid ratio | 2.2 (1.2–4.0) | 1.25 (0.7–2.5) | * |
| Cold ischemic time (min) | 397.0 (311.0–494.0) | 444.0 (369.0–529.0) | * |
| Warm-ischemic time (min) | 41.0 (36.0–47.0) | 51.0 (42.0–61.0) | * |
| Surgery time (min) | 348.0 (280.5–424.5) | 383.0 (325.0–425.0) | 0.002* |
| Intraoperative CRRT | 110 (7.3%) | 170 (25.7%) | * |
| Veno-venous bypass usage | 327 (38.1%) | 346 (47.2%) | * |
| Post-reperfusion syndrome | 125 (15.4%) | 134 (21.2%) | 0.004* |
| Intraoperative vasopressor infusion | 604 (76.6%) | 573 (91.1%) | * |
| Intraoperative vasopressor intermittent bolus | 272 (32.5%) | 292 (45.8%) | * |
| * | |||